COMMON STOCK PURCHASE WARRANT Techprecision corporationPlacement Agent’s Warrant • July 10th, 2024 • Techprecision Corp • Fabricated structural metal products
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 8, 2025 (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(g)(8)(A), on or prior to 5:00 p.m. (New York City time) on July 8, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from TechPrecision Corporation, a company incorporated under the laws of the State of Delaware (the “Company”), up to ____ shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT'S WARRANT WARRANT NO. _______ THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE EXERCISE HEREOF, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR FILED OR REGISTERED WITH THE UNITED...Placement Agent's Warrant • May 16th, 2000 • Wavetech International Inc • Telephone communications (no radiotelephone) • Arizona
PLACEMENT AGENT’S WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES CELLECT BIOTECHNOLOGY LTD.Placement Agent's Warrant • February 6th, 2018 • Cellect Biotechnology Ltd. • Surgical & medical instruments & apparatus
THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 31, 2018 (the “Initial Exercise Date”) and on or prior to the close of business on the one year anniversary following the earlier of (i) a registration statement registering the Warrant ADSs under the Securities Act for resale by the Holder has been declared effective by the Commission and (ii) the six (6) months anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cellect Biotechnology Ltd., an Israeli limited company (the “Company”), up to ______ Ordinary Shares (the “Warrant Shares”) represented by ________ American Depositary Shares (“ADSs”), as subject to adjustment hereunder (the “Warrant ADSs”)
EXHIBIT 4.8 - FORM OF PLACEMENT AGENT'S WARRANT THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, OFFERED FOR SALE, ASSIGNED,...Placement Agent's Warrant • October 18th, 1996 • Navidec Inc
